EMA
approval
· 2022-12-16
First gene therapy to treat haemophilia B
Summary
The European Medicines Agency approved the first gene therapy designed to treat haemophilia B, marking a milestone in genetic treatment for this disorder.
Upgrade for the full analysis, importance score, and drug timeline.